Spectrometer for biopharmaceutical applications maXis II™

for protein analysissingle quadrupoleQTOF

Heralds a new era in accurate-mass LC-MS/MS Ultra-High Resolution Unparalleled versatility Unmatched performance to resolve demanding analytical challenges Performance Record-breaking full sensitivity resolution (FSR) of > 80,000. High-definition Five orders of magnitude dynamic range achieved at UHPLC speeds due to 50 GBit/sec sampling technology-definitive trace analysis from complex, high-background matrices. Plug and play One-shot acquisition with triple-quadrupole sensitivity ensuring qualitative and quantitative results in one LC run with fastest time-to-success. Easy expertise Intelligent self-optimizing MS/MS routines for expert-caliber results first time and dedicated application packages. maXis II is THE market leading high-resolution LC-QTOF, leading the way in QTOF technology with unprecedented performance across wide ranging applications, to resolve the most demanding analytical challenges. A full range of specified performance parameters is delivered simultaneously. Bruker's Ultra-High Resolution QTOF (UHR) technology has reached new standards in accurate-mass LC-MS/MS. In addition, the system offers Electron-Transfer Dissociation (ETD) capabilities for sequence analysis of intact proteins including monoclonal antibody subunits. Furthermore, native state samples, including antibody drug conjugates, can be measured at these enhanced performance levels (Native Mass Spectrometry). Antibody Characterization - Intact and Subunit Analysis